Aging: effect on ex-vivo benzodiazepine binding after a diazepam injection

Area of Science:

• Neuropharmacology
• Gerontology
• Radioligand Binding Assays

Background:

• Benzodiazepines are widely used anxiolytic and sedative drugs.
• Age-related changes in drug metabolism and receptor sensitivity are common.
• Understanding how aging affects benzodiazepine receptor binding is crucial for optimizing therapeutic use.

Purpose of the Study:

• To investigate the effect of acute diazepam administration on benzodiazepine receptor occupation in rats of different ages.
• To differentiate between benzodiazepine receptor subtypes (BZ1 and BZ2) and assess age-related binding changes.

Main Methods:

• Ex vivo [3H]flunitrazepam receptor binding assays were performed on brain tissue from young, mature, and old male Fischer 344 rats.
• Diazepam was administered intravenously as a single low dose.
• Benzodiazepine receptor subtypes were distinguished using the selective ligand CL 218,872.

Main Results:

• Acute diazepam injection significantly decreased [3H]flunitrazepam binding in senescent rats.
• Binding was reduced at both BZ1 and BZ2 receptor subtypes in old rats.
• Young and mature rats did not show a significant decrease in receptor binding after diazepam administration.

Conclusions:

• Aging alters benzodiazepine receptor sensitivity to acute diazepam exposure.
• Both BZ1 and BZ2 receptor subtypes are affected by age, leading to reduced binding in senescent individuals.
• These findings suggest potential age-dependent pharmacokinetic or pharmacodynamic changes in benzodiazepine action.